rs2069506

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005981.5(TSPAN31):​c.*1781C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.331 in 1,346,344 control chromosomes in the GnomAD database, including 81,582 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 6737 hom., cov: 32)
Exomes 𝑓: 0.34 ( 74845 hom. )

Consequence

TSPAN31
NM_005981.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.205

Publications

20 publications found
Variant links:
Genes affected
TSPAN31 (HGNC:10539): (tetraspanin 31) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is thought to be involved in growth-related cellular processes. This gene is associated with tumorigenesis and osteosarcoma. [provided by RefSeq, Jul 2008]
CDK4 (HGNC:1773): (cyclin dependent kinase 4) The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported. [provided by RefSeq, Jul 2008]
CDK4 Gene-Disease associations (from GenCC):
  • melanoma, cutaneous malignant, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 12-57749071-C-A is Benign according to our data. Variant chr12-57749071-C-A is described in ClinVar as Benign. ClinVar VariationId is 1182049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.637 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSPAN31NM_005981.5 linkc.*1781C>A 3_prime_UTR_variant Exon 6 of 6 ENST00000257910.8 NP_005972.1
CDK4NM_000075.4 linkc.819+111G>T intron_variant Intron 7 of 7 ENST00000257904.11 NP_000066.1
TSPAN31NM_001330169.2 linkc.*1781C>A 3_prime_UTR_variant Exon 6 of 6 NP_001317098.1
TSPAN31NM_001330168.2 linkc.*1781C>A 3_prime_UTR_variant Exon 4 of 4 NP_001317097.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSPAN31ENST00000257910.8 linkc.*1781C>A 3_prime_UTR_variant Exon 6 of 6 1 NM_005981.5 ENSP00000257910.3
CDK4ENST00000257904.11 linkc.819+111G>T intron_variant Intron 7 of 7 1 NM_000075.4 ENSP00000257904.5

Frequencies

GnomAD3 genomes
AF:
0.265
AC:
40291
AN:
152066
Hom.:
6734
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0820
Gnomad AMI
AF:
0.385
Gnomad AMR
AF:
0.256
Gnomad ASJ
AF:
0.289
Gnomad EAS
AF:
0.656
Gnomad SAS
AF:
0.491
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.139
Gnomad NFE
AF:
0.314
Gnomad OTH
AF:
0.237
GnomAD4 exome
AF:
0.339
AC:
405229
AN:
1194160
Hom.:
74845
Cov.:
17
AF XY:
0.345
AC XY:
208953
AN XY:
606228
show subpopulations
African (AFR)
AF:
0.0729
AC:
2066
AN:
28342
American (AMR)
AF:
0.334
AC:
14740
AN:
44126
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
7024
AN:
24342
East Asian (EAS)
AF:
0.707
AC:
27212
AN:
38474
South Asian (SAS)
AF:
0.487
AC:
39147
AN:
80422
European-Finnish (FIN)
AF:
0.353
AC:
18775
AN:
53202
Middle Eastern (MID)
AF:
0.191
AC:
1005
AN:
5252
European-Non Finnish (NFE)
AF:
0.321
AC:
278760
AN:
868486
Other (OTH)
AF:
0.320
AC:
16500
AN:
51514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
13549
27098
40646
54195
67744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8266
16532
24798
33064
41330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.265
AC:
40297
AN:
152184
Hom.:
6737
Cov.:
32
AF XY:
0.273
AC XY:
20302
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.0818
AC:
3398
AN:
41544
American (AMR)
AF:
0.256
AC:
3919
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
1004
AN:
3470
East Asian (EAS)
AF:
0.655
AC:
3381
AN:
5158
South Asian (SAS)
AF:
0.491
AC:
2368
AN:
4818
European-Finnish (FIN)
AF:
0.373
AC:
3953
AN:
10592
Middle Eastern (MID)
AF:
0.146
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
0.314
AC:
21384
AN:
67996
Other (OTH)
AF:
0.235
AC:
496
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1449
2899
4348
5798
7247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
432
864
1296
1728
2160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.279
Hom.:
835
Bravo
AF:
0.247
Asia WGS
AF:
0.511
AC:
1775
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
5.6
DANN
Benign
0.60
PhyloP100
0.20
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2069506; hg19: chr12-58142854; API